Search clinical trials for: Cordyceps Cicadae Mycelia

Total 48 results

Han-Hsin Chang
Grape King Bio Ltd.

Completed

Alleviating Effects Against High Intraocular Pressure by Oral Intake of Cordyceps Cicadae Mycelia

Supplement

Taiwan
David Pei-Cheng Lin
Grape King Bio Ltd.

Completed

Alleviating Effects Against Dry Eye by Oral Intake of Cordyceps Cicadae Mycelia

Dry Eye | Supplement
China Medical University Hospital

Recruiting

To Study the Effects of Cordyceps Cicadae on Vision Care

Myopia

Taiwan
Chonbuk National University Hospital

Completed

Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

Immunity

Korea, Republic of
Chonbuk National University Hospital

Completed

The Efficacy and Safety of Cordyceps Sinensis Mycelium Culture Extract(Paecilomyces Hepiali, CBG-CS-2) on Promotion of Immunity

Immunity

Korea, Republic of
University of North Carolina, Chapel Hill
Scivation, Inc

Completed

Mushroom Blend on Oxygen Kinetics

Oxygen Utilization | Oxygen Kinetics

United States
Greenyn Biotechnology Co., Ltd.

Recruiting

Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People

Fatigue Syndrome, Chronic | Cold

Taiwan
Second Xiangya Hospital of Central South University

Completed

Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease

Type 2 Diabetes Mellitus | Diabetic Kidney Disease

China
Chung Shan Medical University
Grape King Bio Ltd.

Completed

Erinacine A-enriched Hericium Erinaceus Mycelia for Improvement of Recognition, Vision, and Functional MRI Alterations

Cognition Disorders in Old Age | fMRI | Vision | Supplement

Taiwan
Posit Science Corporation
University of Minnesota

Completed

Care Improving Cognition for ADolescents on the Autism Spectrum (CICADAS)

Autism Spectrum Disorder

United States
University of Phayao
National Innovation Agency (NIA)

Completed

Effect of Cordyceps Militaris Beverage on the Immune Response

Healthy

Thailand
National Cheng-Kung University Hospital

Recruiting

The Effect of Hericium Erinaceus Mycelium in Non-motor Symptoms of Parkinson's Disease

Parkinson Disease

Taiwan
Chung Shan Medical University

Completed

Anti-hypertensive Effect of Mycelia of Antrodia Cinnamomea

Hypertension
Hillel Yaffe Medical Center

Unknown

The Effects of Cordyceps Sinensis and Lingzhi on Cardiovascular Fitness and Cognitive Function

Executive Function | Physical Fitness

Israel
Novena Medical Center

Withdrawn

Wrinkle Injection With Autologous Platelet Rich Plasma Study (WIPES)

Wrinkles

Singapore
University Hospital, Basel, Switzerland
Hoffmann-La Roche

Completed

Scan-rescan Reproducibility of Myelin Sensitive MRI Techniques

Myelin Integrity

Switzerland
Nestlé

Completed

Infant Nutrition and Brain Development

Healthy | Infant Development

United States
OncoVista, Inc.
AAIPharma

Unknown

Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

Refractory TdT-Positive Leukemia

United States
University of California, Davis
National Cancer Institute (NCI); Amino Up Chemicals Co., Ltd.

Recruiting

Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy

Fallopian Tube Carcinoma | Peritoneal Carcinoma | Ovarian Epithelial Carcinoma

United States
University of Brawijaya
PT. Sahabat Lingkungan Hidup

Enrolling by invitation

Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome

Cardiometabolic Syndrome

Indonesia
Sara Varea

Completed

Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B

Multiple Sclerosis | Neuromyelitis Optica

Spain
Nantes University Hospital
Institut National de la Santé Et de la Recherche Médicale, France

Terminated

Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis (TRAP-Myéline)

Multiple Sclerosis

France
California Polytechnic State University-San Luis...

Completed

Effects of Herbal Supplements on Endurance Exercise Performance

Exercise Performance

United States
Chung Shan Medical University

Active, not recruiting

Hericium Erinaceus Mycelium and Probiotic of the Grape King Bio on Symptoms of Premenstrual Syndrome

Premenstrual Syndrome

Taiwan
Lactalis
Biosearch S.A.

Completed

Tolerance of Infants With Cow's Milk Protein Allergy to Extensively Hydrolyzed Rice Protein or Casein Infant Formulas (JUNGLO)

Growth Failure | Tolerance | Cow Milk Protein Sensitivity

Spain
Assiut University

Recruiting

Selective Spinal Anaesthesia With Hyperbaric Prilocain With 2%Provides Better Perioperative Hemodynamic Stability for Patients With Peripheral Vascular Disease and Cardiac Dysfunction in Lower Limb Surgery

Hemodynamic Stability

Egypt
NYU Langone Health

Completed

A Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients

Anxiety

United States
Boston Medical Center
National Cancer Institute (NCI)

Completed

Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia

Leukemia

United States
Hadassah Medical Organization

Completed

T Cell Vaccination in Patients With Progressive Multiple Sclerosis

Multiple Sclerosis

Israel
Georgetown University
Hackensack Meridian Health

Active, not recruiting

A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

Chronic Lymphocytic Leukemia

United States
Light Sciences Oncology

Completed

Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States
Emory University
Genentech, Inc.

Active, not recruiting

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Unresectable Melanoma | Stage III Melanoma | Stage IIIA Skin Melanoma | Cutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IV

United States
Pontificia Universidade Católica do Rio Grande...
Teva Pharmaceuticals USA

Active, not recruiting

A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil (EMOCEMP)

Multiple Sclerosis

Brazil
LifeScan
Evidation Health

Not yet recruiting

Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions (ECLIPSE)

Diabetes Mellitus, Type 2

United States
Fundació Institut Germans Trias i Pujol
Clinica Universidad de Navarra, Universidad de Navarra

Recruiting

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS) (TOLERVIT-MS)

Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting

Spain
Boehringer Ingelheim

Completed

Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

Candidiasis, Oral
Acerta Pharma BV
AstraZeneca

Active, not recruiting

A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

Lymphoma, Mantle Cell

United States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
Washington University School of Medicine
Acerta Pharma BV

Active, not recruiting

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
Weill Medical College of Cornell University

Completed

Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation

Kidney Failure, Chronic

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Active, not recruiting

Polatuzumab Vedotin, Venetoclax, and Rituximab and Hyaluronidase Human for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular... and other conditions

United States
Thomas Jefferson University
National Cancer Institute (NCI)

Recruiting

An Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to Treatment

Recurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Indolent Adult Non-Hodgkin...

United States
National Institute of Allergy and Infectious Diseases...
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

No longer available

B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

Type 1 Diabetes Mellitus

United States
National Cancer Institute (NCI)

Not yet recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma | Follicular Lymphoma With Unusual Cytological Features
Fred Hutchinson Cancer Center

Terminated

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | KSHV-associated Multicentric Castleman Disease

Uganda
National Cancer Institute (NCI)

Recruiting

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Nodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma

United States
University of Washington

Recruiting

Tafasitamab, Retifanlimab, and Rituximab in Combination With Chemotherapy (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) for the Treatment of Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Recruiting

Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
National Cancer Institute (NCI)

Recruiting

Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Primary Mediastinal Large B-Cell Lymphoma

United States, Canada, Australia, Puerto Rico

Search clinical trials for: Cordyceps Cicadae Mycelia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations